BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nie X, Chen Z, Pang L, Wang L, Jiang H, Chen Y, Zhang Z, Fu C, Ren B, Zhang J. Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds. Int J Nanomedicine 2020;15:10215-40. [PMID: 33364755 DOI: 10.2147/IJN.S285134] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Abozaid OAR, El-Sonbaty SM, Hamam NMA, Farrag MA, Kodous AS. Chitosan-Encapsulated Nano-selenium Targeting TCF7L2, PPARγ, and CAPN10 Genes in Diabetic Rats. Biol Trace Elem Res 2023;201:306-23. [PMID: 35237941 DOI: 10.1007/s12011-022-03140-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Natesan V, Kim SJ. The Trend of Organic Based Nanoparticles in the Treatment of Diabetes and Its Perspectives. Biomol Ther (Seoul) 2023;31:16-26. [PMID: 36122910 DOI: 10.4062/biomolther.2022.080] [Reference Citation Analysis]
3 Pires PC, Paiva-Santos AC, Veiga F. Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy. Pharmaceutics 2022;14. [PMID: 36559318 DOI: 10.3390/pharmaceutics14122825] [Reference Citation Analysis]
4 El-dakroury WA, Zewail MB, Amin MM. Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant/type 2 diabetic rat model. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104040] [Reference Citation Analysis]
5 Kambale EK, Quetin-Leclercq J, Memvanga PB, Beloqui A. An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations. Pharmaceutics 2022;14:2135. [PMID: 36297570 DOI: 10.3390/pharmaceutics14102135] [Reference Citation Analysis]
6 Saito N, Haniu H, Aoki K, Nishimura N, Uemura T. Future Prospects for Clinical Applications of Nanocarbons Focusing on Carbon Nanotubes. Adv Sci (Weinh) 2022;:e2201214. [PMID: 35754236 DOI: 10.1002/advs.202201214] [Reference Citation Analysis]
7 Liu R, Mathieu C, Berthelet J, Zhang W, Dupret J, Rodrigues Lima F. Human Protein Tyrosine Phosphatase 1B (PTP1B): From Structure to Clinical Inhibitor Perspectives. IJMS 2022;23:7027. [DOI: 10.3390/ijms23137027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Ahmed MM, Anwer MK, Fatima F, Alali AS, Kalam MA, Zafar A, Alshehri S, Ghoneim MM. Development of Apremilast Nanoemulsion-Loaded Chitosan Gels: In Vitro Evaluations and Anti-Inflammatory and Wound Healing Studies on a Rat Model. Gels 2022;8:253. [PMID: 35621551 DOI: 10.3390/gels8050253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Allawadhi P, Singh V, Govindaraj K, Khurana I, Sarode LP, Navik U, Banothu AK, Weiskirchen R, Bharani KK, Khurana A. Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis. Carbohydr Polym 2022;281:118923. [PMID: 35074100 DOI: 10.1016/j.carbpol.2021.118923] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Wang M, Liang Y, Chen K, Wang M, Long X, Liu H, Sun Y, He B. The management of diabetes mellitus by mangiferin: advances and prospects. Nanoscale 2022;14:2119-35. [PMID: 35088781 DOI: 10.1039/d1nr06690k] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 He Y, Chen Z, Nie X, Wang D, Zhang Q, Peng T, Zhang C, Wu D, Zhang J. Recent advances in polysaccharides from edible and medicinal Polygonati rhizoma: From bench to market. Int J Biol Macromol 2022;195:102-16. [PMID: 34896461 DOI: 10.1016/j.ijbiomac.2021.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
12 Priya S, Tyagi A, Singh M, Rawat S, Raizaday A, Singh SK, Gupta G. Advanced drug delivery systems for treatment of diabetes mellitus. Drug Delivery Systems for Metabolic Disorders 2022. [DOI: 10.1016/b978-0-323-99616-7.00025-6] [Reference Citation Analysis]
13 Vinceković M, Jurić S. Application of Encapsulation Technology in the Agri-Food Sector. Food Engineering Series 2022. [DOI: 10.1007/978-3-030-92415-7_13] [Reference Citation Analysis]
14 Danquah MK, Jeevanandam J. Preclinical and clinical evaluation of nanodrugs for diabetes treatment. Emerging Nanomedicines for Diabetes Mellitus Theranostics 2022. [DOI: 10.1016/b978-0-323-85396-5.00011-7] [Reference Citation Analysis]
15 El Awdan SA, F. Asaad G. Liver Fibrosis: Underlying Mechanisms and Innovative Therapeutic Approach. A Review Article. Biomed Pharmacol J 2021;14:1841-1862. [DOI: 10.13005/bpj/2283] [Reference Citation Analysis]
16 Imam SS, Alshehri S, Ghoneim MM, Zafar A, Alsaidan OA, Alruwaili NK, Gilani SJ, Rizwanullah M. Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives. Polymers (Basel) 2021;13:4036. [PMID: 34833334 DOI: 10.3390/polym13224036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
17 Liu J, Song Y, Zhao Q, Wang Y, Li C, Zou L, Hu Y. Effects of Tartary Buckwheat Protein on Gut Microbiome and Plasma Metabolite in Rats with High-Fat Diet. Foods 2021;10:2457. [PMID: 34681506 DOI: 10.3390/foods10102457] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]